Home - Products - Autophagy - Thrombin - H-Gly-Arg-pNA dihydrochloride

H-Gly-Arg-pNA dihydrochloride

CAS No. 125455-61-0

H-Gly-Arg-pNA dihydrochloride( —— )

Catalog No. M34903 CAS No. 125455-61-0

H-Gly-Arg-pNA dihydrochloride (H-Gly-Arg-Pna 2HCl) belongs to the class of peptides that bind to 1,2 thrombin and can be quantified by colorimetric detection at 405 nm as a measure of thrombin activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 323 In Stock
10MG 475 In Stock
25MG 774 In Stock
50MG 1051 In Stock
100MG 1423 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    H-Gly-Arg-pNA dihydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    H-Gly-Arg-pNA dihydrochloride (H-Gly-Arg-Pna 2HCl) belongs to the class of peptides that bind to 1,2 thrombin and can be quantified by colorimetric detection at 405 nm as a measure of thrombin activity.
  • Description
    H-Gly-Arg-pNA dihydrochloride (H-Gly-Arg-Pna 2HCl) belongs to the class of peptides that bind to 1,2 thrombin and can be quantified by colorimetric detection at 405 nm as a measure of thrombin activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Autophagy
  • Target
    Thrombin
  • Recptor
    Thrombin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    125455-61-0
  • Formula Weight
    424.28
  • Molecular Formula
    C14H23Cl2N7O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N=C(N)NCCC[C@H](NC(CN)=O)C(NC1=CC=C(C=C1)[N+]([O-])=O)=O.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Flovagatran

    Flovagatran (TGN 255) is an orally active, potent, and selective inhibitor of thrombin and parenteral direct factor II.Flovagatran is used to study venous thromboembolism.

  • Ximelagatran

    Ximelagatran, a direct thrombin inhibitor, can be taken orally and acts solely by inhibiting the actions of thrombin. Ximelagatran is converted to the active agent melagatran in vivo.

  • Dabigatran etexilate

    A prodrug of BIBR-953, which is a potent nonpeptide thrombin inhibitor with Ki of 4.5 nM.